Bronchiolitis Obliterans


REFERENCES



  1. Abernathy EC, Hruban RH, Baumgartner WA, et al. The two forms of bronchiolitis obliterans in heart-lung transplant recipients. Hum Pathol 1991; 22(11): 1102-1110.
  2. Al-Dossari GA, Jessurun J, Bolman M, et al. Pathogenesis of obliterative bronchiolitis. Possible roles of platelet-derived growth factor and basic fibroblast growth factor. Transplantation 1995; 15(1):143-145.
  3. Allen MD, Burke CM, McGregor CGA, et al. Steroid responsive bronchiolitis after human heart-lung transplantation. J Thorac Cardiovasc Surg 1986; 92(3):449-451.
  4. Anderson WR, Coulon TF, Kiesel TM, et al. Morphologic characteristics of rejection of the baboon lung allograft. Primates Med 1972; 7:81.
  5. Bando K, Paradis IL, Keenan RJ, et al. Comparison of outcomes after single and bilateral lung transplantation for obstructive lung disease. J Heart Lung Transplant 1995; 14(4):692-698.
  6. Barbera JA, Hayashi S, Hergele RG, et al. Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization. Am Rev Respir Dis 1992; 145(4 Pt 1):940-946.
  7. Barnes BA, Flax MH, Burke JF, et al. Experimental pulmonary homografts in the dog. I. Morphological studies. Transplantation 1963; 1:351.
  8. Becroft DM. Bronchiolitis obliterans, bronchiectasis, and other sequelae of adenovirus type 21 infection in young children. J Clin Pathol 1971; 24(1):72-82.
  9. Berg LC, Copenhaer CM, Morrison VA, et al. B-cell lymphoproliferative disorders in solid organ transplant patients: Detection of Epstein-Barr virus by in situ hybridization. Hum Pathol 1992; 23(2):159-163.
  10. Boon AP, O'Brien D, Adams DH. Ten-year review of invasive asperegillosis detected at necropsy.J Clin Pathol 1991; 44(6):452-454.
  11. Brooks RG, Hofflin JM, Jamieson SW, et al. Infectious complications in heart-lung transplant recipients. Am J Med 1985; 79(4): 412-422.
  12. Burke CM, Theodore J, Dawkins KD, et al. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest 1984; 86(6): 824-829.
  13. Burke CM, Glanville AR, Theodore J, et al. Lung immunogenicity, rejection, and obliterative broncholitis. Chest 1987; 92(3):547-549.
  14. Burke CM, Yousem SA, Corris PA. Heart-lung transplantation. Diseases of the Bronchioles, edited by Gary R. Epler. Raven Press, Ltd. 1994.
  15. Byers JM 3d, Sabanayagam P, Baker RR, et al. Pathologic changes in baboon lung allografts. Comparison of two immunosuppression regimes. Ann Surg 1973; 178(6):754-760.
  16. Castaneda AR, Arnar O, Schmidt-Habelbaum, et al. Cardiopulmonary autotransplantation in primates. J Cardiovasc Surg 1972; 13(5):523-531.
  17. Chaparro C, Chamberlain D, Maurer J, et al. Acute lung injury in lung allografts. J Heart Lung Transplant 1995; 14(2):267-273.
  18. Clelland CA, Higenbottam TW, Monk JA, et al. Bronchoalveolar lavage lymphocytes in relation to transbronchial lung biopsy in heart-lung transplants. Transplant Proc 1990; 22(4):1479.
  19. Clelland C, Higenbottam T, Otulana B, et al. Histologic prognostic indicators for the lung allografts of heart-lung transplants. J Heart Transplant 1990; 9(3 Pt 1):177-185.
  20. Clelland C, Higenbottam T, Stewart S, et al. Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients. Studies of cell counts, lymphocyte phenotypes, and expression of HLA-DR and interleukin-2 receptor. Am Rev Respir Dis 1993; 147(6 Pt 1):1386-1392.
  21. Dark J, Corris PA. The current state of lung transplantation. Thorax 1989; 44(9):689-692.
  22. de Blic J, Peuchmaur M, Carnot F, et al. Rejection in lung transplantation - an immunohistochemical study of transbronchial biopsies. Transplantation 1992; 54(4):639-644.
  23. De Hoyos A, Chamberlain D, Schvartzman R, et al. Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation. Chest 1993; 103(6):1813-1818.
  24. Denning DW, Follansbee SE, Scolaro M, et al. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324(10): 654-662.
  25. Duncan AJ, Dummer JS, Paradis IL, et al. Cytomegalovirus infection and survival in lung transplant recipients. J Heart Lung Transplant 1991; 10(5 Pt 1):638-644.
  26. Dummer JS, Montero CG, Griffith BP, et al. Infections in heart-lung transplant recipients. Transplantation 1986; 41(6):725-729.
  27. Dummer JS, White LT, Ho M, et al. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis 1985; 152(6): 1182-1191.
  28. Epler GR, Colby TV. The spectrum of bronchiolitis obliterans. Chest 1983; 83(2): 161-162.
  29. Fournier M, Lebargy F, Le Roy Ladurie F, et al. Intraepithelial T-lymphocyte subsets in the airways of normal subjects and of patients with chronic bronchitis. Am Rev Respir Dis 1989; 140(3): 737-742.
  30. Frizzera G, Hanot DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 1981; 41(11 Pt 1):4262-4279.
  31. Frost AE, Keller CA, Noon GP, et al. Outcome of the native lung after single lung transplant. Multiorgan Transplant Group. Chest 1995; 107(4):981-984.
  32. Fujimura S, Rosen V, Adomian GE, et al. Cellular characteristics of the rejection response to canine lung allotransplants. J Thorac Cardiovasc Surg 1973; 65(3):438-448.
  33. Glanville AR, Baldwin JC, Burke CM, et al. Obliterative bronchiolitis after heart-lung transplantation: Apparent arrest by augmented immunosuppression. Ann Intern Med 1987; 107(3): 300-304.
  34. Glanville AR, Tazelaar HD, Theodore J, et al. The distribution of MHC class I and II antigens on bronchial epithelium. Am Rev Respir Dis 1989; 139(2): 330-334.
  35. Goldman M, Gerard C, Abramowicz D, et al. Induction of interleukin-6 and interleukin-10 by the OKT3 monoclonal antibody: Possible relevance to posttransplant lymphroliferative disorders. Clin Transplant 1992; 6: 265-268.
  36. Gray J, Wreghitt TG, Pavel P, et al. Epstein -Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact. J Heart Lung Transplant 1995; 14(4):640-646.
  37. Griffith BP, Hardesty RL, Trento A, et al. Heart-lung transplantation: lessons learned and future hopes. Ann Thorac Surg 1987; 43(1):6-16.
  38. Grinnan GL, Graham WH, Childs JW, et al. Cardiopulmonary homotransplantation. J Thorac Cardiovasc Surg 1970; 60(5):609-615.
  39. Gryzan S, Paradis IL, Zeevi A, et al. Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. Am Rev Respir Dis 1988; 137(6):1268-1274.
  40. Hanto DW. Polyclonal and monoclonal post-transplant lymphoproliferative disease (LPD). Clin Transplant 1992; 6:227-234.
  41. Harjula AL, Baldwin JC, Glanville AR, et al. Human leukocyte antigen compatibility in heart-lung transplantation. J Heart Transplant 1987; 6(3):162-166.
  42. Hasegawa S, Ockner DM, Ritter JH, et al. Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic pulmonary transplant rejection. Arch Pathol Lab Med 1995; 119:432-439.
  43. Haverich A, Dawkins KD, Baldwin JC, et al. Long-term cardiac and pulmonary histology in primates following combined heart and lung transplantation. Transplantation 1985; 39(4):356-360.
  44. Herridge MS, de Hoyos AL, Chaparro C, et al. Pleural complications in lung transplant recipients. J Thorac Cardiovasc Surg 1995; 110(1):22-26.
  45. Higenbottam TW, Penketh AR, Stewart S, et al. The diagnosis of lung rejection and opportunistic lung infection of heart-lung transplant patients using transbronchial lung biopsy. Transplantation 1988; 46: 532.
  46. Higenbottam T, Stewart S, Penketh A, et al. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation 1988; 46(4):532-539.
  47. Higenbottam TW, Stewart S. Transbronchial lung biopsy in the diagnosis of rejection of the tranplanted lung. In: Wallwork JL, ed. Heart and Lung Transplantation. Philadelphia: WB Saunders, 1989.
  48. Hines DW, Haber MH, Yaremko L, et al. Pseudomembranous tracheobronchitis caused by Aspergillus. Am Rev Respir Dis 1991; 143(6):1408-1411.
  49. Holland VA, Cale PT, Windsor NT, et al. Lymphocyte subset populations in bronchiolitis obliterans after heart-lung transplantation. Transplantation 1990; 50(6): 955-959.
  50. Hruban RH, Beschorner WE, Baumgartner WA, et al. Diagnosis of lung allograft rejection by bronchial intraepithelial Leu-7 positive T lymphocytes. J Thorac Cariovasc Surg 1988; 96(6): 939-946.
  51. Hruban RH, Beschorner WE, Baumgartner WA, et al. Depletion of bronchus-associated lymphoid tissue associated with lung allograft rejection. Am J Pathol 1988; 132(1): 6-11.
  52. Hruban RH, Hutchins GM. The pathology of lung transplantation. In: Baumgartner WA, Achuff SC, Reitz BA, eds. Heart-Lung Transplantation. Philadelphia: WB Saunders, 1990; 372.
  53. Humbert M, Deveregne O, Cerrina J, et al. Activation of macrophages and cytotoxic cells during cytomegalovirus pneumonia complicating lung transplantations. Am Rev Respir Dis 1992; 145(5): 1178-1184.
  54. Hunninghake GW, Kawanami O, Ferrans VJ, et al. Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis 1981; 123(4 Pt 1):407-412.
  55. Hunt JB, Stewart S, Cary N, et al. Evaluation of the International Society for Heart Transplantation grading of pulmonary rejection in 100 consecutive biopsies. Transplant Int 5 1992; 5:249.
  56. Hutter JA, Despins P, Higenbottam T, et al. Heart-lung transplantation: Better use of resources. Am J Med 1988 85(1):4-11.
  57. Hutter JA, Stewart S, Higenbottam TW, et al. The characteristic histological changes associated with rejection in heart-lung transplant recipients. Transplant Proc 1989; 21(1 Pt 1):435-436.
  58. Hutter JA, Scott J, Wreghitt T, et al. The importance of cytomegalovirus in heart-lung transplant recipients. Chest 1989; 95(3): 627-631.
  59. Katzenstein AL, Askin FB. Surgical Pathology of Non Neoplastic Lung Disease. Philadelphia: WB Saunders, 1982; 349.
  60. Keenan RJ, Lega ME, Dummer JS, et al. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991; 51(2):433-438.
  61. Keller CA, Cagle PT, Brown RW, et al. Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation. Chest 1995; 107(4):973-980.
  62. Keogh A, Kaan A, Doran T, et al. HLA mismatching and outcome in heart, heart-lung, and single lung transplantation. J Heart Lung Transplant 1995; 14(3):444-451.
  63. Kondo Y, Cockrell JV, Kuwahara O, et al. Histopathology of one-stage bilateral lung allografts. Ann Surg 1974; 180(5):753-759.
  64. Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis 1991; 144(3 Pt 1):552-556.
  65. Kriett JM, Kaye MP. The Registry of the International Society for Heart and Lung Transplantation: Eighth Official Report-1991. J Heart Lung Transplant 1991; 10(4):491-498.
  66. Lower RR, Stofer RC, Hurley EJ, et al. Complete homograft replacement of the heart and both lungs. Surgery 1961; 50:842.
  67. Marck KW, Prop J, Wildevuur CR, et al. Lung transplantation in the rat: Histopathology of left lung iso- and allografts. J Heart Transplant 1985; 4(2):263-266.
  68. Maurer JR, Tullis DE, Grossman RF, et al. Infectious complications following isolated lung transplantation. Chest 1992; 101(4):1056-1059.
  69. McCarthy PM, Starnes VA, Theodore J, et al. Improved survival after heart-lung transplantation. J Thorac Cardiovasc Surg 1990; 99(1): 54-59.
  70. Millard PR, Heryet AR. Observations favouring Pneumocystis carinii pneumonia as a primary infection: A monoclonal antibody study on paraffin sections. J Pathol 1988; 154(4):365-370.
  71. Millet B, Higenbottam TW, Flower CD, et al. The radiographic appearances of infection and acute rejection of the lung after heart-lung transplantation. Am Rev Respir Dis 1989; 140(1):62-67.
  72. Milne DS, Gascoigne AD, Ashcroft T, et al. Organizing pneumonia following pulmonary transplantation and the development of obliterative bronchiolitis. Transplantation 1994; 57(12):1757-1762.
  73. Milne DS, Gascoigne AD, Wilkes J, et al. MHC class II and ICAM-1 expression and lymphocyte subsets in transbronchial biopsies from lung transplant recipients. Transplantation 1994; 57(12):1762-1766.
  74. Myerson D, Hackman RC, Nelson JA, et al. Widespread presence of histologically occult cytomegalovirus. Hum Pathol 1984; 15(5): 430-439.
  75. Nalesnik MA, Locker J, Jaffe R, et al. Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients. Clin Transplantation 1992; 6: 249-252.
  76. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133(1):173-192.
  77. Nathan SD, Ross DJ, Belman MJ, et al. Bronchiolitis obliterans in single-lung transplant recipients. Chest 1995; 107(4):967-972.
  78. Nibbering PH, van der Heide A, van Furth R. Macrophages in broncho-alveolar lavage fluid are not representative of macrophages in granulomas of the lungs of BCG-infected mice. J Pathol 1989; 157(3): 253-261.
  79. Niedobitek G, Finn T, Herbst H, et al. Detection of cytomegalovirus by in situ hybridization and immunohistochemistry using new monoclonal antibody CCH2: a comparison of methods. J Clin Pathol 1988; 41(9):1005-1009.
  80. Norin AJ, Emeson EE, Kamholz SL, et al. Cyclosporine A as the initial immunosuppressive agent for canine lung transplantation. Short- and long-term assessment of rejection phenomena. Transplantation 1982; 34(6):372-375.
  81. Paradis IL, Marrari M, Zeevi A, et al. HLS phenotype of lung lavage cells following heart-lung transplantation. J Heart Transplant 1985; 4(4): 422-425.
  82. Pennington JE. Aspergillus lung disease. Med Clin North Am 1980; 64(3):475-490.
  83. Pomerance A, Madden B, Burke MM, et al. Transbronchial biopsy in heart and lung transplantation: clinicopathologic correlations. J Heart Lung Transplant 1995; 14(4):761-773.
  84. Prop J, Nieuwenhuis P, Wildevuur CR. Lung allograft rejection in the rat. I. accelerated rejection caused by graft lymphocytes. Transplantation. 1985; 40(1):25-30.
  85. Prop J, Kuijpers K, Petersen AH, et al. Why are lung allografts more vigorously rejected than hearts? J Heart Transplant 1985; 4(4):433-436.
  86. Prop J, Tazelaar HD, Billingham ME. Rejection of combined heart-lung transplants in rats. Function and pathology. Am J Pathol 1987; 127(1):97-105.
  87. Prop J, Wildevuur CR, Niewenhuis P. Lung allograft rejection in the rat. II. Specific immunological properties of lung grafts. Transplantation 1985; 40(2):126-131.
  88. Prop J, Wildevuur CR, Nieuwenhuis P. Lung allograft rejection in the rat. III. Corresponding morphological rejection phases in various rat strain combinations. Transplantation 1985; 40(2):132-136.
  89. Reinsmoen NL, Bolman RM, Savik K, et al. Differentiation of class I- and class II-directed donor-specific alloreactivity in bronchoalveolar lavage lymphocytes from lung transplant recipients. Transplantation 1992; 53(1):181-189.
  90. Reitz BA, Burton NA, Jamieson SW, et al. Heart and lung transplantation: Autotransplantation and allotransplantation in primates with extended survival. J Thorac Cardiovasc Surg 1980; 80(3):360-372.
  91. Randhawa PS, Yousem SA, Paradis IL, et al. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol 1989; 92(2): 177-185.
  92. Romaniuk A, Prop J, Petersen AH, et al. Expression of class II major histocompatibility complex antigens by bronchial epithelium in rat lung allografts. Transplantation 1987; 44(2): 209-214.
  93. Rosendale B, Yousem SA. Discrimination of Epstein-Barr virus-related posttransplant lymphoproliferations from acute rejection in lung allograft recipients. Arch Pathol Lab Med 1995; 119(5):418-423.
  94. Schafers HJ, Haydock DA, Cooper JD. The prevalence and management of bronchial anastomotic complications in lung transplantation. J Thorac Cardiovasc Surg 1991: 101(6):1044-1052.
  95. Scott JP, Higenbottam TW, Clelland CA, et al. Natural history of chronic rejection in heart-lung transplant recipients. J Heart Transplant 1990; 9(5): 510-515.
  96. Scott JP, Higenbottam TW, Sharples L, et al. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation 1991; 51(4): 813-817.
  97. Shennib H, Nguyen D, Guttmann RD, et al. Phenotypic expression of bronchoalveolar lavage cells in lung rejection and infection. Ann Thorac Surg 1991; 51(4): 630-635.
  98. Sissons JG, Borysiewicz LK. Human cytomegalovirus infection. Thorax 1989; 44(4): 241-246.
  99. Stewart S. Pathology of lung transplantation. Semin Diagn Pathol 1992; 9(3):210-219.
  100. Stewart S, Cary N. The pathology of heart and heart and lung transplantation- an update. J Clin Pathol 1991; 44(10):803-811.
  101. Stewart S, Higenbottam TW, Hutter JA, et al. Histopathology of transbronchial biopsies in heart-lung transplantation. Transplant Proc 1988; 20(1):764-766.
  102. Su IJ, Lin KH, Chen CJ, et al. Epstein-Barr virus-associated peripheral T-cell lymphoma of activated CD8 phenotype. Cancer 1990; 66(12): 2557-2562.
  103. Sundaresan S, Alevy YG, Steward N, et al. Cytokine gene transcripts for tumor necrosis factor-alpha, interleukin-2, and interferon-gamma in human pulmonary allografts. J Heart Lung Transplant 1995; 14(3):512-518.
  104. Sundaresan S, Semenkovich J, Ochoa L, et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg 1995; 109(6):1075-1079.
  105. Smyth RL, Scott JP, Borysiewicz LK, et al. Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment. J Infect Dis 1991; 164(6): 1045-1050.
  106. Smyth RL, Higenbottam TW, Scott JP, et al. Herpes simplex virus infection in heart-lung transplant recipients. Transplantation 1990; 49(4): 735-739.
  107. Swerdlow SH. Post-transplant lymphoproliferative disorders: A morphologic, phenotypic and genotypic spectrum of disease. Histopathology 1992; 20(5):373-385.
  108. Travis WD, Pittaluga S, Lipschik GY, et al. Atypical pathologic manifestations of pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Review of 123 lung biopsies from 76 patients with emphasis on cysts, vascular invasion, vasculitis, and granulomas. Am J Surg Pathol 1990; 14(7): 615-625.
  109. Tazelaar HD. Perivascular inflammation in pulmonary infections: Implications for the diagnosis of lung rejection. J Heart Lung Transplant 1991; 10(3):437-441.
  110. Tazelarr HD, Baird AM, Mill M, et al. Bronchocentric mycosis occurring in transplant recipients. Chest 1989; 96(1):92-95.
  111. Tazelaar HD, Prop J. Nieuwenhuis P, et al. Airway pathology in the transplanted rat lung. Transplantation 1988; 45(5):864-869.
  112. Tazelaar HD, Yousem SA. The pathology of combined heart-lung transplantation: An autopsy study. Hum Pathol 1988; 19(12):1403-1416.
  113. Theodore J, Lewiston N. Lung transplantation comes of age. N Engl J Med 1990; 332(11):772-774.
  114. Trulock EP. Management of lung transplant rejection. Chest 1993; 103(5):1566-1576.
  115. Trulock EP, Bolamn RM, Genton R. Pulmonary disease caused by mycobacterium chelonae in a heart-lung transplant recipient with obliterative bronchiolitis. Am Rev Respir Dis 1989; 140(3):802-805.
  116. Trulock EP, Ettinger NA, Brunt EM, et al. The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures. Chest 1992; 102(4):1049-1054.
  117. Veal CF Jr, Carr MB, Briggs DD Jr. Diffuse pneumonia and acute respiratory failure due to infectious mononucleosis in a middle-aged adult. Am Rev Respir Dis 1990; 141(2):502-504.
  118. Veith FJ, Hagstrom JWC, Anderson WR, et al. Alveolar manifestations of rejection: An important cause of the poor results with human lung transplantation. Ann Surg 1972; 175(3):336-348.
  119. Veith FJ, Koerner SK, Siegelman SS, et al. Diagnosis and reversal of rejection in experimental and clinical lung allografts. Ann Thorac Surg 1973; 16(2):172-183.
  120. Veith FJ, Norin AJ, Montefusco CM, et al. Cyclosporine A in experimental lung transplantation. Transplantation 1981; 32(6):474-481.
  121. Walker RC, Paya CV, Marshall WF, et al. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant 1995; 14(2):214-221.
  122. Walters EH, Gardiner PV. Bronchoalveolar lavage as a research tool. Thorax 1991; 46(9):613-618.
  123. Walts AE, Marchevsky AM, Morgan M. Pulmonary cytology in lung transplant recipients: recent trends in laboratory utilization. Diagn Cytopathol 1991; 7(4):353-358.
  124. Weber WR, Askin FB, Dehner LP. Lung biopsy in Pneumocystis carinii pneumonia: A histopathologic study of typical and atypical features. Am J Clin Pathol 1977; 67(1):11-19.
  125. Weiss LM, Movahed LA, Berry GJ, et al. In situ hybridization studies for viral nucleic acids in heart and lung allograft biopsies. Am J Clin Pathol 1990; 93(5): 675-679.
  126. Wendt CH, Fox JM, Hertz MI. Paramyxovirus infection in lung transplant recipients. J Heart Lung Transplant 1995; 14(3):479-485.
  127. Winter JB, Clelland C, Gouw AS, et al. Distinct phenotypes of infiltrating cells during acute and chronic lung rejection in human heart-lung transplants. Transplantation 1995; 59(1):63-69.
  128. Winter JB, Groen M, Welling S, et al. Inadequate antibody response against respiratory viral infection in long-surviving rat lung allografts. Transplantation 1995; 59(11):1583-1589.
  129. Wreghitt TG, Hakim M, Gray JJ, et al. Toxoplasmosis in heart and heart and lung transplant recipients. J Clin Pathol 1989; 42(2):194-199.
  130. Wyatt SE, Nunn P, Hows JM, et al. Airways obstruction associated with graft versus host disease after bone marrow transplantation. Thorax 1984; 39(12): 887-894.
  131. Yousem SA, Berry GJ, Brunt EM, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. J Heart Transplant 1990; 9(6):593-601.
  132. Yousem SA, Burke CM, Billingham ME. Pathologic pulmonary alterations in long-term human heart-lung transplantation. Hum Pathol. 1985; 16(9):911-923.
  133. Yousem SA, Curley JM, Dauber J, et al. HLA-class II antigen expression in human heart-lung allografts, Transplantation 1990; 49(5): 991-995.
  134. Yousem SA, Paradis IL, Dauber JH, et al. Efficacy of transbronchial lung biopsy in the diagnosis of bronchiolitis obliterans in heart-lung transplant recipients. Transplantation 1989; 47(5):893-895.
  135. Yousem SA, Dauber JA, Keenan R, et al. Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation 1991; 52(2): 306-309.
  136. Yousem SA, Duncan SR, Griffith BP. Interstitial and airspace granulation tissue reactions in lung transplant recipients. Am J Surg Pathol. 1992; 16(9):877-884.
  137. Yousem SA, Isaacs A. Pulmonary neuroendocrine cells in the airways of lung allografts. Transplantation 1995; 59(7):1070-1073.
  138. Yousem SA, Paradis IL, Dauber JH, et al. Pulmonary arteriosclerosis in long-term human heart-lung transplant recipients. Transplantation 1989; 47(3):564-569.
  139. Yousem SA, Randhawa P, Locker J, et al. Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol. 1989; 20(4):361-369.
  140. Yousem SA, Tazelaar HD. Combined heart-lung transplantation. In: Sale GE, ed. The Pathology of Organ Transplantation. Boston: Butterworths, 1990: 153.
  141. Zeevi A, Fung JJ, Paradis IL, et al. Lymphocytes of bronchoalveolar lavages from heart-lung transplant recipients. J Heart Transplant 1985; 4(4):417-421.




Please mail comments, corrections or suggestions to the TPIS administration at the UPMC.

Last Modified: Thu Jun 18 10:14:08 EDT 2009